liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Association of a protective paraoxonase 1 (PON1) polymorphism in Parkinson's disease
Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Show others and affiliations
2012 (English)In: Neuroscience Letters, ISSN 0304-3940, E-ISSN 1872-7972, Vol. 522, no 1, p. 30-5Article in journal (Refereed) Published
Abstract [en]

Pesticide exposure has been suggested to increase the risk to develop Parkinson's disease (PD). The arylesterase paraoxonase 1 (PON1) is mainly expressed in the liver and hydrolyzes organophosphates such as pesticides. The polymorphism Leu54Met (rs854560) in PON1, impairing enzyme activity and leading to decreased PON1 expression levels, has been reported to be associated with Parkinson's disease (PD). PON1 is part of a cluster on chromosome 7q21.3 together with PON2 and PON3. We investigated the occurrence of four additional polymorphisms in PON1 and two in PON2 in a Swedish PD case-control material. We found a significant association (p=0.007) with a PON1 promoter polymorphism, rs854571. The minor allele was more common among controls than PD cases which suggest a protective effect. This is strengthened by the fact that rs854571 is in strong linkage disequilibrium with another PON1 promoter polymorphism, rs854572, reported to increase PON1 gene expression. Our findings support the hypothesis that PON1 is involved in the etiology of PD and that higher PON1 levels are reducing the risk for PD.

Place, publisher, year, edition, pages
Elsevier, 2012. Vol. 522, no 1, p. 30-5
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:liu:diva-80804DOI: 10.1016/j.neulet.2012.06.007ISI: 000307035700007PubMedID: 22704918OAI: oai:DiVA.org:liu-80804DiVA, id: diva2:548324
Note

funding agencies|Swedish Research Council||Magnus Bergvall Foundation||Swedish Parkinson Foundation||Swedish Brain Foundation||Swedish Brain Power||Ake Wiberg Foundation||Karolinska Institutet Funds||

Available from: 2012-08-30 Created: 2012-08-30 Last updated: 2018-01-12

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMed

Authority records BETA

Söderkvist, PeterDizdar (Dizdar Segrell), NilAhmadi, Ahmad

Search in DiVA

By author/editor
Söderkvist, PeterDizdar (Dizdar Segrell), NilAhmadi, Ahmad
By organisation
Faculty of Health SciencesCell BiologyDivision of Cell BiologyDepartment of Neurology
In the same journal
Neuroscience Letters
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 158 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf